Department of Endocrinology, Metabolism and Prevention of Cardiovascular Diseases

The Endocrinology-Metabolism department headed by Prof. Bruckert comprises two units: one for hypothalamic-pituitary pathologies and a unit for the management of severe dyslipidemia (Lipidology).

The lipidology unit includes

a day hospital platform (55 patients per week) and functional exploration for cardiovascular prevention (stress test, echocardiography, evaluation of retinal microcirculation by optical coherence, Echo-Doppler of peripheral arteries
A functional LDL apheresis treatment unit (80 patients) within a common hemobiotherapy federation,
A consultation platform (7000 consultations for dyslipidemia per year).

Areas of clinical and research expertise

the management of lipid diseases (excess triglyceride cholesterol, metabolic syndrome) with international notoriety on the rarest and most serious diseases (for example 50 homozygous familial hypercholesterolaemia, 4 patients with Refsum disease, 30 familial hyperchylomicronemia, 8 patients with sistosterolemia, 5000 patients with heterozygous familial hypercholesterolemia including more than 400 children)
The pathologies treated in the department require therapeutic education programs, in particular for the metabolic syndrome. These are validated by the ARS
The unit benefits from an exceptional environment with up-to-date radiology services (coroscanner, calcium score), genetics (genetic diagnosis of familial hypercholesterolemia, hyperchylomicronemia and genetic hypoHDLemia) and lipidology (hormonal assays and assays of lipids including the most specialized assays)
The unit coordinates with the Marseille center the national register of familial hypercholesterolemia.